{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-003829","form_type":"8-K","ticker":"PMCB","cik":"0001157075","company_name":"PharmaCyte Biotech, Inc.","filed_at":"2021-08-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.317588+00:00","generated_at":"2026-06-29T08:19:43.418454+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PharmaCyte Biotech raises $70M in registered direct offering and private placement","bullets":["Gross proceeds ~$70M from sale of 8.43M shares and 5.57M pre-funded warrants at $5.00 per share.","Unregistered Series A warrants for 7M shares at $5.00, exercisable immediately, 5-year term.","Net proceeds to address FDA clinical hold on IND for Phase 2b trial in pancreatic cancer and fund trial.","H.C. Wainwright acting as exclusive placement agent; closing expected on or about August 23, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-003829","json":"https://secwatch.observer/filing/0001683168-21-003829.json","markdown":"https://secwatch.observer/filing/0001683168-21-003829.md","text":"https://secwatch.observer/filing/0001683168-21-003829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157075/000168316821003829/0001683168-21-003829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157075/000168316821003829/pharmacyte_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T08:19:43.418454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}